This is a guest-post by Jeffrey Draa, CEO at Grolltex - producing graphene biosensors on silicon chips today shows low yields, high cost and restrictive packaging options, limiting scalability and market penetration. But optimization may be here.
Monolayer, electronics grade graphene is propelling advanced biosensing in many key areas. Google the search term, ‘graphene biosensor’, and one will see thousands of next-generation, life enhancing applications being refined in research labs worldwide. This one atom thick material is creating biosensing and detection performance in speed and sensitivity not possible before. Areas such as cancer and virus detection, new drug discovery, genomics, allergens, glucose and many more are starting to see unimagined advances. By far, the number 1 use case for monolayer graphene films today is atomic level biosensing.